Tirzepatide conjugated with BSA protein {BSA} (STJP012953)
SPECIFICATIONS
ConjugationBSA
ImmunogenHomo sapiens (Human)
General Information
| Short Description | Tirzepatide conjugated with BSA-protein was developed from. For use in research applications. |
| Applications | ELISA/WB |
| Note | STRICTLY FOR FURTHER SCIENTIFIC RESEARCH USE ONLY (RUO). MUST NOT BE USED IN DIAGNOSTIC OR THERAPEUTIC APPLICATIONS. |
Product Properties
| Conjugation | BSA |
| Dilution Range | Reconstitute in sterile water for a stock solution. |
| Formulation | Lyophilized from a solution in PBS pH 7.4, 1mM EDTA, 4% Trehalose, 1% Mannitol. |
| Storage Instruction | Use a manual defrost freezer and avoid repeated freeze thaw cycles. Store at 2 to 8°C for one week. Store at-20 to-80°C for twelve months from the date of receipt. |
| Endotoxin | Please contact us for this information. |
Target Information
| Immunogen | Homo sapiens (Human) |
| Immunogen Region | Biosynthetic peptide |